FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379469946> ?p ?o ?g. }

• W4379469946 abstract "University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary series and/or booster dose vaccine received, we conducted serologic investigations in September and December 2021 on a large university campus in Wisconsin to assess anti-SARS-CoV-2 antibody levels.We collected blood samples, demographic information, and COVID-19 illness and vaccination history from a convenience sample of students. Sera were analyzed for both anti-spike (anti-S) and anti-nucleocapsid (anti-N) antibody levels using World Health Organization standardized binding antibody units per milliliter (BAU/mL). Levels were compared across categorical primary COVID-19 vaccine series received and binary COVID-19 mRNA booster status. The association between anti-S levels and time since most recent vaccination dose was estimated by mixed-effects linear regression.In total, 356 students participated, of whom 219 (61.5%) had received a primary vaccine series of Pfizer-BioNTech or Moderna mRNA vaccines and 85 (23.9%) had received vaccines from Sinovac or Sinopharm. Median anti-S levels were significantly higher for mRNA primary vaccine series recipients (2.90 and 2.86 log [BAU/mL], respectively), compared with those who received Sinopharm or Sinovac vaccines (1.63 and 1.95 log [BAU/mL], respectively). Sinopharm and Sinovac vaccine recipients were associated with a significantly faster anti-S decline over time, compared with mRNA vaccine recipients (P <.001). By December, 48/172 (27.9%) participants reported receiving an mRNA COVID-19 vaccine booster, which reduced the anti-S antibody discrepancies between primary series vaccine types.Our work supports the benefit of heterologous boosting against COVID-19. COVID-19 mRNA vaccine booster doses were associated with increases in anti-SARS-CoV-2 antibody levels; following an mRNA booster dose, students with both mRNA and non-mRNA primary series receipt were associated with comparable levels of anti-S IgG." @default.
• W4379469946 created "2023-06-07" @default.
• W4379469946 creator A5000945652 @default.
• W4379469946 creator A5000947410 @default.
• W4379469946 creator A5008166934 @default.
• W4379469946 creator A5011205755 @default.
• W4379469946 creator A5022396107 @default.
• W4379469946 creator A5027087100 @default.
• W4379469946 creator A5027549150 @default.
• W4379469946 creator A5035899856 @default.
• W4379469946 creator A5037513467 @default.
• W4379469946 creator A5039162530 @default.
• W4379469946 creator A5039449249 @default.
• W4379469946 creator A5040696722 @default.
• W4379469946 creator A5043171450 @default.
• W4379469946 creator A5045117577 @default.
• W4379469946 creator A5047668057 @default.
• W4379469946 creator A5048413586 @default.
• W4379469946 creator A5049932573 @default.
• W4379469946 creator A5053228595 @default.
• W4379469946 creator A5060513146 @default.
• W4379469946 creator A5061848201 @default.
• W4379469946 creator A5066471470 @default.
• W4379469946 creator A5071457160 @default.
• W4379469946 creator A5075445486 @default.
• W4379469946 creator A5077431761 @default.
• W4379469946 creator A5092093763 @default.
• W4379469946 date "2023-06-05" @default.
• W4379469946 modified "2023-10-13" @default.
• W4379469946 title "Assessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses — fall 2021, Wisconsin" @default.
• W4379469946 cites W3046550871 @default.
• W4379469946 cites W3098210359 @default.
• W4379469946 cites W3124922922 @default.
• W4379469946 cites W3135594926 @default.
• W4379469946 cites W3137970801 @default.
• W4379469946 cites W3165566490 @default.
• W4379469946 cites W3173738234 @default.
• W4379469946 cites W3174017401 @default.
• W4379469946 cites W3189374801 @default.
• W4379469946 cites W3193784398 @default.
• W4379469946 cites W3193970389 @default.
• W4379469946 cites W3196397911 @default.
• W4379469946 cites W3196746379 @default.
• W4379469946 cites W3199384045 @default.
• W4379469946 cites W3203377713 @default.
• W4379469946 cites W3211888797 @default.
• W4379469946 cites W3217661335 @default.
• W4379469946 cites W4200033584 @default.
• W4379469946 cites W4206906464 @default.
• W4379469946 cites W4210450230 @default.
• W4379469946 cites W4212781360 @default.
• W4379469946 cites W4213383641 @default.
• W4379469946 cites W4220681045 @default.
• W4379469946 cites W4220692822 @default.
• W4379469946 cites W4220887537 @default.
• W4379469946 cites W4220977324 @default.
• W4379469946 cites W4224303234 @default.
• W4379469946 cites W4225726091 @default.
• W4379469946 cites W4225740414 @default.
• W4379469946 cites W4226287603 @default.
• W4379469946 cites W4280562953 @default.
• W4379469946 cites W4283207872 @default.
• W4379469946 cites W4283794745 @default.
• W4379469946 cites W4291398405 @default.
• W4379469946 doi "https://doi.org/10.1186/s12879-023-08332-7" @default.
• W4379469946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37277736" @default.
• W4379469946 hasPublicationYear "2023" @default.
• W4379469946 type Work @default.
• W4379469946 citedByCount "1" @default.
• W4379469946 crossrefType "journal-article" @default.
• W4379469946 hasAuthorship W4379469946A5000945652 @default.
• W4379469946 hasAuthorship W4379469946A5000947410 @default.
• W4379469946 hasAuthorship W4379469946A5008166934 @default.
• W4379469946 hasAuthorship W4379469946A5011205755 @default.
• W4379469946 hasAuthorship W4379469946A5022396107 @default.
• W4379469946 hasAuthorship W4379469946A5027087100 @default.
• W4379469946 hasAuthorship W4379469946A5027549150 @default.
• W4379469946 hasAuthorship W4379469946A5035899856 @default.
• W4379469946 hasAuthorship W4379469946A5037513467 @default.
• W4379469946 hasAuthorship W4379469946A5039162530 @default.
• W4379469946 hasAuthorship W4379469946A5039449249 @default.
• W4379469946 hasAuthorship W4379469946A5040696722 @default.
• W4379469946 hasAuthorship W4379469946A5043171450 @default.
• W4379469946 hasAuthorship W4379469946A5045117577 @default.
• W4379469946 hasAuthorship W4379469946A5047668057 @default.
• W4379469946 hasAuthorship W4379469946A5048413586 @default.
• W4379469946 hasAuthorship W4379469946A5049932573 @default.
• W4379469946 hasAuthorship W4379469946A5053228595 @default.
• W4379469946 hasAuthorship W4379469946A5060513146 @default.
• W4379469946 hasAuthorship W4379469946A5061848201 @default.
• W4379469946 hasAuthorship W4379469946A5066471470 @default.
• W4379469946 hasAuthorship W4379469946A5071457160 @default.
• W4379469946 hasAuthorship W4379469946A5075445486 @default.
• W4379469946 hasAuthorship W4379469946A5077431761 @default.
• W4379469946 hasAuthorship W4379469946A5092093763 @default.
• W4379469946 hasBestOaLocation W43794699461 @default.
• W4379469946 hasConcept C12590561 @default.
• W4379469946 hasConcept C126322002 @default.
• W4379469946 hasConcept C159654299 @default.
• W4379469946 hasConcept C187212893 @default.

• next